Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor

Investigative Radiology

Volumn 32, Issue 12, 1997, Pages 748-754

  Wiener, Erik C ^a,b   Konda, Sheela ^a   Shadron, Amber ^a   Brechbiel, Martin ^c   Gansow, Otto ^c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b University of Illinois at Urbana Champaign   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Contrast agents; Dendrimer; Folate; Gadolinium

Indexed keywords

2 (4 ISOTHIOCYANATOBENZYL) 6 METHYLDIETHYLENETRIAMINEPENTAACETIC ACID; CARBOXYTETRAMETHYLRHODAMINE SUCCINIMIDYL ESTER; CELL RECEPTOR; CHELATE; DENDRIMER; DYE; FLUORESCEIN ISOTHIOCYANATE; FOLIC ACID; PENTETIC ACID DERIVATIVE; POLYAMIDOAMINE; POLYMER; SUCCINIC ANHYDRIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG TARGETING; ERYTHROLEUKEMIA CELL; FLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; TUMOR; TUMOR CELL;

EID: 0031434670     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199712000-00005     Document Type: Article

References (14)

1. Wiener EC, Brechbiel MW, Brothers H, et al. Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents. Magn Reson Med 1994;31:1-8.
2. Gansow OA, Wu C. Advanced methods for radiolabeling monoclonal antibodies with therapeutic radionuclides. In: Goldenberg DM, ed. Cancer therapy with radiolabeled antibodies. Boca Raton: CRC Press, 1995:63-76.
3. Wiener EC, Auteri FP, Chen JW, et al. Molecular dynamics of ion-chelate complexes attached to dendrimers. J Am Chem Soc 1996;118:7774-7782.
4. Leamon CP, Low PS. Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis. Proc Natl Acad Sci 1991;88:5572-5576.
5. Garin-Chesa P, Campbell I, Saigo PE, Lewis JL, Old LJ, Rettig WJ. Trophoblast and ovarian cancer antigen LK26. Am J Pathol 1993;142:557-567.
6. Weitman SD, Lark RH, Coney LR, et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 1992;52:3396-3401.
7. Campbell IG, Jones TA, Foulkes WD, Trowsdale J. Folate-binding protein is a marker for ovarian cancer. Cancer Res 1991; 51:5329-5338.
8. Rettig WJ, Cordon-Cardo C, Koulos JP, Lewis JL, Oettgen HF, Old LJ. Cell surface antigens of human trophoblast and choriocarcinoma defined by monoclonal antibodies. Int J Cancer 1985;35:469-475.
9. Weitman SD, Frazier KM, Kamen BA. The folate receptor in central nervous system malignancies of childhood. J Neurooncol 1994;21:107-112.
10. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Cancer 1994;73:2432-2443.
11. Kamen BA, Capdevila A. Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc Natl Acad Sci U S A 1986;83:5983-5987.
12. Anderson RGW, Kamen BA, Rothberg KG, Lacey SW. Potocytosis: Sequestration and transport of small molecules by caveolae. Science 1992;255:410-411.
13. Kane MA, Portillo RW, Elwood PC, Antony AC, Kolhouse JF. The influence of extracellular folate concentration on methotrexate uptake by human KB cells. Partial characterization of a membrane-associated methotrexate binding protein. J Biol Chem 1986;261:44-49.
14. Eckelman WC, Tweedle M, Welch MJ. 1988. NMR enhancement with Gd labeled antibodies. Nato ASI (Series A: Life Sciences) 1988; 152, 571.